Food and Drug
Law Journal
(This is a truly excellent journal
for legal information about therapeutic products)
| Title | Link |
|---|---|
| Paul V. Buday - Hints on Preparing Successful Orphan Drug Designation Requests - Food and Drug Law Journal - (10 pages) | http://www.fdli.org/pubs/Journal%20Online/51_1/art4.pdf |
| Stephen Paul Mahinka & KathleenM. Sanzo - Pharmaceutical Industry Restructuring and New Marketing Approaches: Enforcement Responses - Food and Drug Law Journal (13 pages) | http://www.fdli.org/pubs/Journal%20Online/50_2/art9.pdf |
| David A. Balto & James F. Mongoven - Antitrust Enforcement in Pharmaceutical Industry Mergers - Food and Drug Law Journal - (24 pages) | http://www.fdli.org/pubs/Journal%20Online/54_3/art%201.pdf |
| Josha P. Cohen - PBMs and a Medicare Prescription Drug Benefit - Food and Drug Law Journal - (10 pages) | http://www.fdli.org/pubs/Journal%20Online/55_3/art3.pdf |
| Food and Drug Law Journal, Online Articles and Abstracts | http://www.fdli.org/pubs/Journal%20Online/journalarticles.html |
| Edward M. Basile, Ellen Armentrout & Kelly N. Reeves, Medical Device Labeling and Advertising: An Overview, 54 Food and Drug Law Journal 519-534 (1999) - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art2.pdf |
| J. Howard Beales III, Modification and Consumer Information: Modern Biotechnology and the Regulation of Information, 55 Food and Drug Law Journal 105-118 (2000) - (14 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art6.pdf |
| Eric M. Blumberg, Abbott Laboratories Consent Decree and Individual Responsibility Under the Federal Food, Drug, and Cosmetic Act, 55 Food and Drug Law Journal 145-150 (2000) - (6 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art9.pdf |
| David C. Vladeck , Devaluing Truth: Unverified Health Claims in the Aftermath of Pearson v. Shalala, 54 Food and Drug Law Journal at 535 - (20 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art3.pdf |
| Richard F. Kingham and Grant H. Castle - Data and Marketing Exclusivity for Pharmaceuticals in the European Community - 55 Food and Drug Law Journal 209 - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/55_2/art3.pdf |
| Leah Brannon, Regulating Drug Promotion on the Internet, 54 Food and Drug Law Journal 599-622 (1999), | http://www.fdli.org/pubs/Journal%20Online/54_4/art8.pdf |
| John Y. Chai, Medical Device Regulation in the United States and the European Union: A Comparative Study, 55 Food and Drug Law Journal 57-80 (2000), | http://www.fdli.org/pubs/Journal%20Online/55_1/art4.pdf |
| GERALD J. MOSSINGHOFF - Overview of the Hatch-Waxman Act and Its Impact on the Drug Development Process - 54 Food and Drug Law Journal 187 (1999) | http://www.fdli.org/pubs/Journal%20Online/54_2/art2.pdf |
| Several articles on the history of FDA - Food and Drug Law Journal 50th anniversary Special Issue - 1995 | http://www.fdli.org/pubs/Journal%20Online/jour_toc/vol50_Special.html |
| Stuart L. Nightingale - Challenges in Human Subject Protection - 50 Food and Drug Law Journal 493-501 (1995) - (9 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art3.pdf |
| Sheila R. Shulman and Jeffrey S. Brown - The Food and Drug Administration’s Early Access and Fast-Track Approval Initiatives: How Have They Worked? - 50 Food and Drug Law Journal 385-388 (1995) - (29 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art4.pdf |
| Jur Strobos - Stoning A Dead Bird: Advertising Limits on Approved New Drugs - 50 Food and Drug Law Journal533-551 (1995) - (19 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art5.pdf |
| William Green - Consumer-Directed Advertising of Contraceptive Drugs: The FDA, Depo-Provera, and Product Liability - 50 Food and Drug Law Journal 553-567 (1995) - (15 pages) | http://www.fdli.org/pubs/Journal%20Online/50_4/art6.pdf |
| Lisa A. Foley / Mark D.Whitener - Competition and Antitrust Enforcement in the Changing Pharmaceutical Marketplace - 50 Food and Drug Law Journal 309-312 (1995) - (7 pages) | http://www.fdli.org/pubs/Journal%20Online/50_2/art7.pdf |
| Stephen Paul Mahinka and Kathleen M. Sanzo - Pharmaceutical Industry Restructuring and New Marketing Approaches: Enforcement Responses - 50 Food and Drug Law Journal 313-326 (1995) - (13 pages) | http://www.fdli.org/pubs/Journal%20Online/50_2/art9.pdf |
| Stephen H. McNamara - Dietary Supplements of Botanicals and Other Substances: A New Era of Regulation - 50 Food and Drug Law Journal341-348 (1995) - (8 pages) | http://www.fdli.org/pubs/Journal%20Online/50_3/art1.pdf |
| C. Lee Peeler and Susan Cohn - The Federal Trade Commission's Regulation of Advertising Claims for Dietary Supplements - 50 Food and Drug Law Journal 349-355 (1995) - (7 pages) | http://www.fdli.org/pubs/Journal%20Online/50_3/art2.pdf |
| William C. MacLeod and J. Howard Beales - Assessments of Pharmaceutical Advertisements: A Critical Analysis of the Criticism - 50 Food and Drug Law Journal 415-449 (1995) - (35 pages) | http://www.fdli.org/pubs/Journal%20Online/50_3/art8.pdf |
| Linda R. Horton - Medical Device Regulation in the European Union - 50 Food and Drug Law Journal 461-476 (1995) - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/50_3/art11.pdf |
| David Woodward - The New Drug Marketing: A Consumer Protection Perspective - 51 Food and Drug Law Journal 637-650 (1996) - (14 pages) | http://www.fdli.org/pubs/Journal%20Online/51_4/art11.pdf |
| Elizabeth C. Price - Teaching the Elephant to Dance: Privatizing the FDA Review Process - 51 Food and Drug law Journal 651-676 (1996) - (26 pages) | http://www.fdli.org/pubs/Journal%20Online/51_4/art12.pdf |
| Marc J. Scheineson - Legal Overview of Likely FDA Regulation of Internet Promotion - 51 Food and Drug Law Journal 697-716 (1996) - (20 pages) | http://www.fdli.org/pubs/Journal%20Online/51_4/art14.pdf |
Back to country: United States
Last updated: July 7, 2002